Evidence-based psychosocial intervention for families with childhood cancer patients

2010 ◽  
Author(s):  
Yin-ching Luk
2018 ◽  
Vol 36 (1) ◽  
pp. 55-68 ◽  
Author(s):  
Daisy E. Collins ◽  
Sarah J. Ellis ◽  
Madeleine M. Janin ◽  
Claire E. Wakefield ◽  
Kay Bussey ◽  
...  

Background: One in four school-aged children is bullied. However, the risk may be greater for childhood cancer patients/survivors (diagnosed <18 years), because of symptoms of the disease and treatment that may prejudice peers. While the serious consequences of bullying are well documented in the general population, bullying may have even greater impact in children with cancer due to the myriad of challenges associated with treatment and prolonged school absence. Objective: To summarize the state of evidence on bullying in childhood cancer patients/survivors; specifically, the rate and types of bullying experienced and the associated factors. Method: We searched five electronic databases from inception to February 2018 for original research articles reporting on bullying in childhood cancer patients/survivors. Results: We identified 29 eligible articles, representing 1,078 patients/survivors ( M = 14.35 years). Self-reports from patients/survivors revealed a considerably higher rate of bullying (32.2%) compared with the general population (25%). Our review identified little information on the factors associated with bullying in patients/survivors. However, the bullying described tended to be verbal and was often related to the physical side effects of treatment, indicating that differences in appearance may prejudice peers. It was further suggested that educating the child’s classmates about cancer may prevent bullying. Conclusions: Our findings confirm that bullying is a significant challenge for many childhood cancer patients/survivors. Additional studies are needed to identify factors that may influence the risk of bullying, which will inform the development of evidence-based interventions and guidelines to prevent bullying in childhood cancer patients/survivors.


2014 ◽  
Vol 24 (4) ◽  
pp. 465-471 ◽  
Author(s):  
Elisabeth M. van Dijk-Lokkart ◽  
Katja I. Braam ◽  
Jaap Huisman ◽  
Gertjan JL Kaspers ◽  
Tim Takken ◽  
...  

2015 ◽  
Vol 23 (8) ◽  
pp. 2327-2333 ◽  
Author(s):  
Elisabeth M. van Dijk-Lokkart ◽  
Katja I. Braam ◽  
Gertjan J. L. Kaspers ◽  
Eline van Dulmen-den Broeder ◽  
Tim Takken ◽  
...  

2018 ◽  
Vol 14 (2) ◽  
pp. 112-124
Author(s):  
Daniel J. Kilpatrick ◽  
Kathleen B. Cartmell ◽  
Abdoulaye Diedhiou ◽  
K. Michael Cummings ◽  
Graham W. Warren ◽  
...  

Introduction: Continued smoking by cancer patients causes adverse cancer treatment outcomes, but few patients receive evidence-based smoking cessation as a standard of care.Aim: To evaluate practical strategies to promote wide-scale dissemination and implementation of evidence-based tobacco cessation services within state cancer centers.Methods: A Collaborative Learning Model (CLM) for Quality Improvement was evaluated with three community oncology practices to identify barriers and facilitate practice change to deliver evidence-based smoking cessation treatments to cancer patients using standardized assessments and referrals to statewide smoking cessation resources. Patients were enrolled and tracked through an automated data system and received follow-up cessation support post-enrollment. Monthly quantitative reports and qualitative data gathered through interviews and collaborative learning sessions were used to evaluate meaningful quality improvement changes in each cancer center.Results: Baseline practice evaluation for the CLM identified the lack of tobacco use documentation, awareness of cessation guidelines, and awareness of services for patients as common barriers. Implementation of a structured assessment and referral process demonstrated that of 1,632 newly registered cancer patients,1,581 (97%) were screened for tobacco use. Among those screened, 283 (18%) were found to be tobacco users. Of identified tobacco users, 207 (73%) were advised to quit. Referral of new patients who reported using tobacco to an evidence-based cessation program increased from 0% at baseline across all three cancer centers to 64% (range = 30%–89%) during the project period.Conclusions: Implementation of quality improvement learning collaborative models can dramatically improve delivery of guideline-based tobacco cessation treatments to cancer patients.


The Breast ◽  
2018 ◽  
Vol 41 ◽  
pp. S15
Author(s):  
Icro Meattini ◽  
Matteo Lambertini ◽  
Isacco Desideri ◽  
Alex De Caluwé ◽  
Orit Kaidar-Person ◽  
...  

2012 ◽  
Vol 59 (4) ◽  
pp. 657-661 ◽  
Author(s):  
Ping-ping Bao ◽  
Ying Zheng ◽  
Chun-xiao Wu ◽  
Peng Peng ◽  
Yang-ming Gong ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document